Skip to main content
Caplight Logo









ZBiotics

ZBiotics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://zbiotics.com/

Last Round

Series A

Aug 27, 2024

Est. Valuation

$1.71M

Total Funding Raised

$17.7M

Company Overview

ZBiotics is a biotechnology company that develops genetically engineered probiotics designed to improve human health by addressing everyday biological challenges, such as breaking down alcohol byproducts.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

synthetic biologygenetically engineered probiotichangover curepre-alcohol probioticfunctional beverageDTCdirect-to-consumergut healthbioengineered bacteriaacetaldehyde breakdownhangover preventionsynbioprobiotic supplementconsumer healthsubscription supplement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZBiotics Comparables

Compare ZBiotics with similar companies based on industry and business-model similarity.

ZBiotics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
More Labs
84%
de Faire Medical AB
80%
No Days Wasted
80%

ZBiotics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 27, 2024
SeedMar 12, 2020
AcceleratorAug 7, 2018
SeedMar 21, 2018

Key People

Founding team and executive leadership

Zachary Abbott

Founder, CEO

Founding Team

ZBiotics Investors

Notable investors and investment history

ZBiotics investors
InvestorRounds
Utopian VenturesSeed
Oyster VenturesSeed
Access CapitalSeries A
Seamless CapitalSeries A
BABEL VenturesSeed
Babel VenturesSeed
Seamless CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2024

    $12M round completed.

  • Jan 1, 2024

    Sugar-to-Fiber, a probiotic drink mix, is launching in 2024.

Recent news

Latest coverage and updates

  • receives_awardJun 14, 2026

    Zbiotics, Inc. receives award Silver OMA.

ZBiotics Filings

Explore SEC and related filing metadata, where available.

ZBiotics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ZBiotics's valuation, stock price, and market status.

Is ZBiotics a public or private company?

ZBiotics is a private company.

What is the current stock price of ZBiotics?

ZBiotics is a private company with no public stock price. No recent secondary market data is available.

How much is ZBiotics worth (valuation)?

ZBiotics's valuation is estimated at $1.7M based on funding round data.

Can I buy ZBiotics stock?

ZBiotics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ZBiotics's last funding round?

ZBiotics's most recent funding round was Series A on August 7, 2018.

Who are the main investors in ZBiotics?

Key investors in ZBiotics include Oyster Ventures, Babel Ventures, Spring Tide Capital.

Will ZBiotics IPO soon?

No public IPO plans have been announced for ZBiotics.

How can I track ZBiotics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ZBiotics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range45
Year Founded2016
Last FundingAug 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?